Clinical Trial Update: Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors [NA]

View source ↗

Summary

A clinical trial update concerning the proximal resection margin length for Siewert II/III esophagogastric junction tumors; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Gastric Cancer

Snippet

Sponsor: West China Hospital | Conditions: Stomach Neoplasms, Siewert Type II Adenocarcinoma of Esophagogastric Junction | NA | Status: UNKNOWN